The effect of levodopa on saccades – Oxford Quantification in Parkinsonism study

The effect of levodopa on saccades – Oxford Quantification in Parkinsonism study

OBJECTIVES:The evaluation of novel disease modifying drugs requires biomarkers that are simultaneously sensitive to disease state but resistant to the effects of background symptomatic treatment. Saccadic eye movement parameters have been proposed as a neurophysiological biomarker for Parkinson'...

Full description

Bibliographic Details
Main Authors:	Lu, Z, Buchanan, T, Kennard, C, Fitzgerald, J, Antoniades, C
Format:	Journal article
Language:	English
Published:	Elsevier 2019

Similar Items

Using saccades as an early test of levodopa treatment in Parkinson's Disease
by: Lu, Z, et al.
Published: (2018)

Deep brain stimulation and levodopa affect gait variability in Parkinson disease differently
by: Su, ZH, et al.
Published: (2022)

Learning and switching between stimulus-saccade associations in Parkinson's disease.
by: Hodgson, T, et al.
Published: (2013)

Terapi levodopa pada penyakit Parkinson
by: Perpustakaan UGM, i-lib
Published: (2001)

Levodopa and the feedback process on set-shifting in Parkinson's disease
by: Au, Wing Lok, et al.
Published: (2013)

Does levodopa accelerate the pathologic process in Parkinson disease brain?
by: Parkkinen, L, et al.
Published: (2011)

Control of voluntary and reflexive saccades.
by: Walker, R, et al.
Published: (2000)

Defective cortical drive to muscle in Parkinson's disease and its improvement with levodopa.
by: Salenius, S, et al.
Published: (2002)

Cognitive processes in saccade generation.
by: Kennard, C, et al.
Published: (2005)

Formulation optimization of palm-based nanoemulsion containing levodopa, an anti-parkinson’s drug
by: Zainol, Syafinaz
Published: (2014)

STN-DBS reduces saccadic hypometria but not visuospatial bias in Parkinson’s disease patients
by: Fischer, P, et al.
Published: (2016)

BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.
by: Foltynie, T, et al.
Published: (2009)

Improved bioavailability of levodopa using floatable spray-coated microcapsules for the management of Parkinson’s disease
by: Baek, Jong-Suep, et al.
Published: (2019)

Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model
by: Kura, Aminu Umar, et al.
Published: (2014)

IMPAIRED ANTISACCADES IN PARKINSON'S DISEASE
by: Antoniades, C, et al.
Published: (2012)

Oculomotor effects of medical and surgical treatments of Parkinson's disease
by: Patel, S, et al.
Published: (2019)

Development of Levodopa-loaded inhalable dry powders for treatment of Parkinson's disease via the pulmonary system
by: Paul, Mahasweta
Published: (2022)

Potentials and challenges of Levodopa particle formulation for treatment of Parkinson's disease through intranasal and pulmonary delivery
by: Paul, Mahasweta, et al.
Published: (2022)

Supplementary eye field contributions to the execution of saccades to remembered target locations.
by: Rosenthal, C, et al.
Published: (2008)

Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease.
by: Doyle, L, et al.
Published: (2005)

Is levodopa toxic? Insights from pathological studies
by: Parkkinen, L, et al.
Published: (2013)

Assaying the effect of levodopa on the evaluation of risk in healthy humans
by: Symmonds, M, et al.
Published: (2013)

The control of saccades in hoverflies
by: Walker, S, et al.
Published: (2012)

Saccadic eye movement and working memory deficits following damage to human prefrontal cortex.
by: Walker, R, et al.
Published: (1998)

Impaired spatial working memory across saccades contributes to abnormal search in parietal neglect.
by: Husain, M, et al.
Published: (2001)

Pallidal Deep Brain Stimulation Improves Higher Control of the Oculomotor System in Parkinson's Disease
by: Antoniades, CA, et al.
Published: (2015)

Differential cortical activation during voluntary and reflexive saccades in man.
by: Mort, D, et al.
Published: (2003)

UNDERSTANDING THE EARLY PATHOLOGICAL PATHWAYS IN PARKINSON'S DISEASE. THE OXFORD PARKINSON'S DISEASE CENTRE
by: Hu, M, et al.
Published: (2010)

Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
by: Tinazzi, M, et al.
Published: (2014)

Multimodal visual-somatosensory integration in saccade generation.
by: Amlôt, R, et al.
Published: (2003)

Quantification of gait and time perception in Parkinson’s disease
by: Su, ZH
Published: (2022)

Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning
by: De Vos, M, et al.
Published: (2020)

Oculomotor Dysfunction in Parkinson's Disease
by: Kennard, C, et al.
Published: (2013)

Oculomotor Dysfunction in Parkinson's Disease
by: Kennard, C, et al.
Published: (2013)

Acute oral toxicity and biodistribution study of zinc aluminium-levodopa nanocomposite
by: Kura, Aminu Umar, et al.
Published: (2015)

The saccade-related local field potentials of the superior colliculus: a functional marker for localizing the periventricular and periaqueductal gray.
by: Liu, X, et al.
Published: (2009)

Levodopa does not affect expression of reinforcement learning in older adults
by: Grogan, J, et al.
Published: (2019)

Levodopa may improve orthostatic tremor: case report and trial of treatment.
by: Wills, A, et al.
Published: (1999)

Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
by: Rowland, M, et al.
Published: (2016)

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
by: Gray, R, et al.
Published: (2014)